Shimon I - Search Results

1

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and the associated lung neuroendocrine tumors: clinical experience with a rare entity.

Gorshtein A, Gross DJ, Barak D, Strenov Y, Refaeli Y, Shimon I, Grozinsky-Glasberg S. Gorshtein A, et al. Among authors: shimon i. Cancer. 2012 Feb 1;118(3):612-9. doi: 10.1002/cncr.26200. Epub 2011 Jul 12. Cancer. 2012. PMID: 21751183 Free article.

2

A pituitary mass and hypopituitarism: improvement after corticosteroid therapy.

Shimon I, Berezin M, Hadani M, Tadmor R, Gross D, Karasik A. Shimon I, et al. Isr J Med Sci. 1997 Jan;33(1):58-62. Isr J Med Sci. 1997. PMID: 9203520 Review.

3

Pituitary macroadenoma secreting thyrotropin and growth hormone: remission of bihormonal hypersecretion in response to lanreotide therapy.

Shimon I, Nass D, Gross DJ. Shimon I, et al. Pituitary. 2001 Sep;4(4):265-9. doi: 10.1023/a:1020706732701. Pituitary. 2001. PMID: 12501978

4

Medullary thyroid cancer: a retrospective analysis of a cohort treated at a single tertiary care center between 1970 and 2005.

Grozinsky-Glasberg S, Benbassat CA, Tsvetov G, Feinmesser R, Peretz H, Shimon I, Lapidot M. Grozinsky-Glasberg S, et al. Among authors: shimon i. Thyroid. 2007 Jun;17(6):549-56. doi: 10.1089/thy.2006.0229. Thyroid. 2007. PMID: 17614776

5

Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms.

Grozinsky-Glasberg S, Shimon I, Korbonits M, Grossman AB. Grozinsky-Glasberg S, et al. Among authors: shimon i. Endocr Relat Cancer. 2008 Sep;15(3):701-20. doi: 10.1677/ERC-07-0288. Epub 2008 Jun 4. Endocr Relat Cancer. 2008. PMID: 18524947 Review.

6

Long-acting somatostatin analogues are an effective treatment for type 1 gastric carcinoid tumours.

Grozinsky-Glasberg S, Kaltsas G, Gur C, Gal E, Thomas D, Fichman S, Alexandraki K, Barak D, Glaser B, Shimon I, Gross DJ. Grozinsky-Glasberg S, et al. Among authors: shimon i. Eur J Endocrinol. 2008 Oct;159(4):475-82. doi: 10.1530/EJE-08-0420. Epub 2008 Jul 28. Eur J Endocrinol. 2008. PMID: 18662970 Clinical Trial.

7

Unusual clinical presentations of giant prolactinomas.

Grozinsky-Glasberg S, Shimon I. Grozinsky-Glasberg S, et al. Among authors: shimon i. Pituitary. 2011 Dec;14(4):340-4. doi: 10.1007/s11102-008-0160-0. Pituitary. 2011. PMID: 19104942

8

Well-differentiated thyroid carcinoma: comparison of microscopic and macroscopic disease.

Tzvetov G, Hirsch D, Shraga-Slutzky I, Weinstein R, Manistersky Y, Kalmanovich R, Lapidot M, Grozinsky-Glasberg S, Singer J, Sulkes J, Shimon I, Benbassat C. Tzvetov G, et al. Among authors: shimon i. Thyroid. 2009 May;19(5):487-94. doi: 10.1089/thy.2008.0228. Thyroid. 2009. PMID: 19348580

9

Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro.

Gorshtein A, Rubinfeld H, Kendler E, Theodoropoulou M, Cerovac V, Stalla GK, Cohen ZR, Hadani M, Shimon I. Gorshtein A, et al. Among authors: shimon i. Endocr Relat Cancer. 2009 Sep;16(3):1017-27. doi: 10.1677/ERC-08-0269. Epub 2009 Jun 9. Endocr Relat Cancer. 2009. PMID: 19509067

10

The rapamycin-derivative RAD001 (everolimus) inhibits cell viability and interacts with the Akt-mTOR-p70S6K pathway in human medullary thyroid carcinoma cells.

Grozinsky-Glasberg S, Rubinfeld H, Nordenberg Y, Gorshtein A, Praiss M, Kendler E, Feinmesser R, Grossman AB, Shimon I. Grozinsky-Glasberg S, et al. Among authors: shimon i. Mol Cell Endocrinol. 2010 Feb 5;315(1-2):87-94. doi: 10.1016/j.mce.2009.09.027. Epub 2009 Oct 6. Mol Cell Endocrinol. 2010. PMID: 19815051

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

246 results

Search Page

Filters